Compassionate use of psychedelics
Greif, A., & Šurkala, M. | Medicine, Health Care, and Philosophy | 23 September 2020
The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats
Brandt, S. D., Walters, H. M., Partilla, J. S., Blough, B. E., Kavanagh, P. V., & Baumann, M. H. | Psychopharmacology | 01 September 2020
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Ramaekers, J. G., Hutten, N., Mason, N. L., Dolder, P., Theunissen, E. L., Holze, F., ... & Kuypers, K. P. | Journal of Psychopharmacology | 25 August 2020
The rise, fall, and possible rise of LSD
Snelders, S., & Pieters, T. | Tijdschrift Voor Psychiatrie | August 2020
The Current Status of Psychedelics in Psychiatry
Nutt, D., & Carhart-Harris, R. | JAMA psychiatry | 29 July 2020
LSD-induced increases in social adaptation to opinions similar to one’s own are associated with stimulation of serotonin receptors
Duerler, P., Schilbach, L., Stämpfli, P., Vollenweider, F. X., & Preller, K. H. | Scientific reports | 22 July 2020
Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms
Morita, I., Oyama, H., Kiguchi, Y., Oguri, A., Fujimoto, N., Takeuchi, A., ... & Kobayashi, N. | Journal of Pharmaceutical and Biomedical Analysis | 21 July 2020
Ibogaine therapy for addiction: Consumer views from online fora
Barber, M., Gardner, J., Savic, M., & Carter, A. | Journal of Drug Policy | 18 July 2020
Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass
Petranker, R., Anderson, T., & Farb, N. | Frontiers in psychology | 10 July 2020
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
Pottie, E., Cannaert, A., & Stove, C. P | Archives of Toxicology | 5 July 2020
Historic psychedelic drug trials and the treatment of anxiety disorders
Weston, N. M., Gibbs, D., Bird, C. I., Daniel, A., Jelen, L. A., Knight, G., & Rucker, J. J. | Depression and Anxiety | 05 July 2020
Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials
Cozzi, N. V., & Daley, P. F. | Drug Testing and Analysis | 01 July 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. | Expert Review of Clinical Pharmacology | 1 June 2020
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. | The Journal of Antibiotics | 12 May 2020
Chronic pain and psychedelics: a review and proposed mechanism of action
Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020
The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review
Bornemann, J. | Journal of Psychoactive Drugs | 2 May 2020
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin
Dahmane, E., Hutson, P. R., & Gobburu, J. V. | Clinical Pharmacology in Drug Development | 06 April 2020
Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.
O’Callaghan, C., Hubik, D. J., Dwyer, J., Williams, M., & Ross, M. | Journal of Music Therapy | 30 March 2020
Long-term effects of psychedelic drugs: A systematic review
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. | Neuroscience & Biobehavioral Reviews | 15 March 2020
The Psychedelic Renaissance and Its Forensic Implications
Holoyda, B. | The journal of the American Academy of Psychiatry and the Law | 09 Mar 2020
Psilocybin Therapeutic Research: The Present and Future Paradigm
Kargbo, R. B. | ACS Medicinal Chemistry Letters | 2 March 2020
Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., ... & Stahl, S. | American Journal of Psychiatry | 1 February 2020
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. | Journal of Psychopharmacology | 16 January 2020
A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine
Palamar, J. J., & Acosta, P. | Clinical and Experimental | 07 January 2020